ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry

April 25, 1980